RSSAcne

Efficacy and Safety Evaluation of High-density Intense Pulsed Light in the Treatment of Grades II and IV Acne Vulgaris as Monotherapy in Dark-skinned Women of Child Bearing Age

Efficacy and Safety Evaluation of High-density Intense Pulsed Light in the Treatment of Grades II and IV Acne Vulgaris as Monotherapy in Dark-skinned Women of Child Bearing Age

| April 1, 2018

by Ajay J. Deshpande, MBBS, DVD, DNB Dr. Deshpande is with the Maharashtra Medical Foundation Joshi Hospital in Pune, India. Funding: No funding was provided for this article. Disclosures: The author has no conflicts of interest relevant to the content of this article. Abstract: Background: Acne vulgaris is a self-limiting, chronic inflammatory disorder of the […]

Continue Reading

A Review of the Safety and Efficacy of Benzoyl Peroxide (5.3%) Emollient Foam in the Management of Truncal Acne Vulgaris

A Review of the Safety and Efficacy of Benzoyl Peroxide (5.3%) Emollient Foam in the Management of Truncal Acne Vulgaris

| November 5, 2010 | 0 Comments

Joseph Bikowski, MD Clinical Assistant Professor, Department of Dermatology, Ohio State University, Columbus, Ohio; Bikowski Skin Care Center at Sewickley Station, Sewickley, Pennsylvania Dr. Bikowski discloses the following: Allergan—speakers’ bureau, honoraria; Coria—advisory board, consultant, honoraria, speakers’ bureau; Galderma—advisory board, consultant, honoraria, speakers’ bureau; OrthoNeutrogena—advisory board, consultant, honoraria, speakers’ bureau; Stiefel, a GSK Company—advisory board, consultant, […]

Continue Reading

A Meta-analysis to Investigate the Relation Between Fitzpatrick Skin Types and Tolerability of Adapalene-Benzoyl Peroxide Topical Gel in Subjects with Mild or Moderate Acne

A Meta-analysis to Investigate the Relation Between Fitzpatrick Skin Types and Tolerability of Adapalene-Benzoyl Peroxide Topical Gel in Subjects with Mild or Moderate Acne

| August 5, 2010 | 0 Comments

Valerie D. Callender, MD is from Callender Skin and Laser Center, Mitchellville, Maryland. Norman Preston, PhD; Cris Osborn, PhD; Lori Johnson, PhD; and Ronald W. Gottschalk, MD are from Galderma Laboratories, LP, Fort Worth, Texas Disclosure: Dr. Callender is a clinical researcher and consultant for Galderma. Drs. Preston, Osborn, Johnson, and Gottschalk are employed by […]

Continue Reading

Three-dimensional, Full-sized, Silicone-based, Facial Replicas for Teaching Outcome Measures in Acne

Three-dimensional, Full-sized, Silicone-based, Facial Replicas for Teaching Outcome Measures in Acne

| June 10, 2010 | 0 Comments

Jerry K. L. Tan, MD, FRCPC; Jing Tang, MSc Dr. Tan is Adjunct Professor, University of Western Ontario and Windsor Clinical Research Inc., Windsor, Ontario, Canada. Jing Tang is Statistician, Windsor Clinical Research Inc., Windsor, Ontario, Canada (currently with Fraser Health Authority, Vancouver, British Columbia, Canada)

Continue Reading

A Review of Acne in Ethnic Skin: Pathogenesis, Clinical Manifestations, and Management Strategies

A Review of Acne in Ethnic Skin: Pathogenesis, Clinical Manifestations, and Management Strategies

| April 7, 2010 | 0 Comments

Erica C. Davis, MD; Valerie D. Callender, MD Dr. Davis is from Callender Skin & Laser Center, Mitchellville, Maryland. Dr. Callendar is from Callender Skin & Laser Center, Mitchellville, Maryland and Department of Dermatology, Howard University College of Medicine, Washington, DC.

Continue Reading

A Three-Step Acne System Containing Solubilized Benzoyl Peroxide versus Benzoyl Peroxide/Clindamycin in Pediatric Patients with Acne

A Three-Step Acne System Containing Solubilized Benzoyl Peroxide versus Benzoyl Peroxide/Clindamycin in Pediatric Patients with Acne

| November 6, 2009 | 0 Comments

Lawrence F. Eichenfield, MD, Rady Children’s Hospital, San Diego, and University of California San Diego, San Diego, California; Diane Thiboutot, MD, Penn State University College of Medicine, Hershey, Pennsylvania; Alan Shalita, MD, SUNY Downstate Medical Center, Brooklyn, New York; Leonard Swinyer, MD, Dermatology Research Center, Salt Lake City, Utah; Emil Tanghetti, MD, Center for Dermatology […]

Continue Reading

The Use of Sodium Sulfacetamide 10%-Sulfur 5% Emollient Foam in the Treatment of Acne Vulgaris

The Use of Sodium Sulfacetamide 10%-Sulfur 5% Emollient Foam in the Treatment of Acne Vulgaris

| August 12, 2009 | 0 Comments

James Q. Del Rosso, DO, FAOCD, Valley Hospital Medical Center, Las Vegas, Nevada Abstract Acne vulgaris is the most common disorder encountered in ambulatory clinical practice comprising 11.3 percent of office visits to dermatologists in 2005.[1] By comparison, eczematous dermatoses, psoriasis, and skin cancer accounted for 6.2, 3.5, and 10 percent of office visits, respectively.[1] […]

Continue Reading